References
- NICE TA127 Technology Appraisal. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease. NICE. 2011. Chapt. 1–8.
- Takaya T, Okamoto M, Yodoi K, et al. Torsades de Pointes with QT prolongation related to donepezil use. J Cardiol. 2009;54:507–511.
- Krahn LE, Lee J, Richardson JW, et al. Hypokalemia leading to torsades de pointes. Munchausen's disorder or bulimia nervosa. Gen Hosp Psychiatry. 1997;19:370–377.
- Kitt J, Irons R, Al-Obaidi M, et al.A case of donepezil-related torsades de pointes. BMJ Case Rep. 2015;2015:bcr2015211900.
- From FDA reports: Aricept and Hypokalaemia, eHealthME. December 2018. https://www.ehealthme.com/ds/aricept/hypokalemia